TIACCI, Enrico
 Distribuzione geografica
Continente #
NA - Nord America 1.773
EU - Europa 1.754
AS - Asia 325
Continente sconosciuto - Info sul continente non disponibili 3
SA - Sud America 3
AF - Africa 2
OC - Oceania 1
Totale 3.861
Nazione #
US - Stati Uniti d'America 1.770
IT - Italia 573
IE - Irlanda 469
UA - Ucraina 237
SE - Svezia 132
VN - Vietnam 132
HK - Hong Kong 105
FI - Finlandia 84
RU - Federazione Russa 60
DE - Germania 55
BE - Belgio 50
CN - Cina 46
FR - Francia 28
GB - Regno Unito 26
TR - Turchia 23
CH - Svizzera 14
AT - Austria 8
PL - Polonia 7
IN - India 5
LB - Libano 5
GR - Grecia 4
UZ - Uzbekistan 4
EC - Ecuador 3
CA - Canada 2
CI - Costa d'Avorio 2
CZ - Repubblica Ceca 2
ES - Italia 2
EU - Europa 2
IQ - Iraq 2
NL - Olanda 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AU - Australia 1
BD - Bangladesh 1
BG - Bulgaria 1
IR - Iran 1
JP - Giappone 1
MX - Messico 1
Totale 3.861
Città #
Dublin 469
Chandler 410
Perugia 267
San Mateo 218
Dong Ket 132
Jacksonville 109
Hong Kong 105
Altamura 95
Medford 91
Princeton 89
Ann Arbor 77
Lawrence 73
Wilmington 63
Andover 60
Brussels 50
Des Moines 41
Beijing 36
Saint Petersburg 25
Izmir 23
Rome 23
Helsinki 22
Redmond 22
Norwalk 19
Boydton 18
Woodbridge 17
New York 14
San Paolo di Civitate 12
Ashburn 10
Redwood City 10
Terni 10
Houston 8
Moscow 7
Falls Church 6
Chicago 5
Foligno 5
Boardman 4
Duncan 4
Frankfurt am Main 4
Lausanne 4
Verona 4
Dearborn 3
Gradara 3
Kraków 3
Prata Di Pordenone 3
Scafa 3
Abidjan 2
Bacoli 2
Collazzone 2
Cornedo Vicentino 2
Den Haag 2
Geneva 2
Guangzhou 2
Guayaquil 2
Ivrea 2
Lappeenranta 2
Madrid 2
Nanning 2
Oxford 2
Paris 2
Parma 2
San Diego 2
Shanghai 2
Tappahannock 2
Allentown 1
Auburn Hills 1
Belgioioso 1
Bologna 1
Brno 1
Cambridge 1
Collegeville 1
Dallas 1
Faenza 1
Fairburn 1
Falkenstein 1
Frankfurt Am Main 1
Fremont 1
Hangzhou 1
Hyderabad 1
Kagoya 1
London 1
Los Angeles 1
Melbourne 1
Milan 1
Montignoso 1
Montreal 1
Mumbai 1
Nanjing 1
Ottawa 1
Philadelphia 1
Phoenix 1
Pisa 1
Quito 1
Salford 1
San Giuliano Milanese 1
Seelze 1
Serio 1
Todi 1
Tong 1
Valle 1
Vienna 1
Totale 2.749
Nome #
Arsenic trioxide and all-trans retinoic acid target NPM1 mutant oncoprotein levels and induce apoptosis in NPM1-mutated AML cells 100
Mutated nucleophosmin detects clonal multilineage involvement in acute myeloid leukemia: Impact on WHO classification 95
Acute myeloid leukemia with mutated nucleophosmin (NPM1): is it a distinct entity? 87
Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma 85
Acute myeloid leukemia bearing cytoplasmic nucleophosmin (NPMc+AML) shows a distinct gene expression profile characterized by up-regulation of genes involved in stem-cell maintenance 78
Pervasive mutations of JAK-STAT pathway genes in classical Hodgkin lymphoma 77
ARSENIC TRIOXIDE AND ALL-TRANS-RETINOIC ACID TARGET NPM1 MUTANT ONCOPROTEIN LEVELS AND INDUCE APOPTOSIS IN NPM1-MUTATED AML CELLS 77
Genomics of Hairy cell leukemia 73
A microRNA signature specific for hairy cell leukemia and associated with modulation of the MAPK-JNK pathways. 68
Simple diagnostic assay for hairy cell leukaemia by immunocytochemical detection of annexin A1 (ANXA1). 68
Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell Leukemia 67
Tumor protein D52 (TPD52): a novel B-cell/plasma-cell molecule with unique expression pattern and Ca(2+)-dependent association with annexin VI. 65
Mutational landscape of AML with normal cytogenetics: biological and clinical implications 63
Blastic plasmacytoid dendritic cell neoplasm and chronic myelomonocytic leukemia: a shared clonal origin 63
Aberrant somatic hypermutation in tumor cells of nodular lymphocyte-predominant and classical Hodgkin's lymphoma. 62
Analyzing primary Hodgkin and Reed-Sternberg cells to capture the molecular and cellular pathogenesis of classical Hodgkin lymphoma. 61
The NPM1 wild-type OCI-AML2 and the NPM1-mutated OCI-AML3 cell lines carry DNMT3A mutations. 60
Immunohistochemistry predicts nucleophosmin (NPM) mutations in acute myeloid leukemia 59
Primary Burkitt's lymphoma of bladder in patient with AIDS. 59
IRTA1 is selectively expressed in nodal and extranodal marginal zone lymphomas. 59
Absence of BRAF-V600E in the human cell lines BONNA-12, ESKOL, HAIR-M, and HC-1 questions their origin from hairy cell leukemia. 59
Aspects of gene expression in B cell lymphomas 59
BRAF mutations in hairy-cell leukemia. 58
High-Risk Clonal Hematopoiesis as the Origin of AITL and NPM1-Mutated AML 58
Improved achiral and chiral hplc-uv analysis of ruxolitinib in two different drug formulations 58
Evolving concepts in the pathogenesis of hairy-cell leukaemia. 56
Constant activation of the RAF-MEK-ERK pathway as a diagnostic and therapeutic target in hairy cell leukemia. 54
BRAF V600E mutation in hairy cell leukemia: From bench to bedside 53
Aberrant subcellular expression of nucleophosmin and NPM-MLF1 fusion protein in acute myeloid leukaemia carrying t(3;5): a comparison with NPMc+ AML. 52
Choroidal vasculature analysis in MEK inhibitor-associated retinopathy 51
Whole-Exome Sequencing Identifies Recurrent Mutations of BCOR in Acute Myeloid Leukemia with Normal Karyotype 50
ALK signaling and target therapy in anaplastic large cell lymphoma 49
Aberrant somatic hypermutation in tumor cells of nodular-lymphocyte-predominant and classic Hodgkin lymphoma. 48
The BRAF-V600E mutation in hematological malignancies: a new player in hairy cell leukemia and Langerhans cell histiocytosis. 48
THE BRAF-MEK-ERK PATHWAY IN HAIRY CELL LEUKEMIA: A COMPREHENSIVE DISSECTION IN PRIMARY LEUKEMIC CELLS OF ITS BIOLOGICAL AND THERAPEUTIC RELEVANCE 48
Dactinomycin induces complete remission associated with nucleolar stress response in relapsed/refractory NPM1-mutated AML 48
Gene expression profiling of isolated tumour cells from anaplastic large cell lymphomas: insights into its cellular origin, pathogenesis and relation to Hodgkin lymphoma. 48
The authors reply 47
Hairy Cell Leukemia Biomarkers and Methods of Using Same 46
The human NPM1 mutation A perturbs megakaryopoiesis in a conditional mouse model. 46
Mouse models of NPM1-mutated acute myeloid leukemia: biological and clinical implications 46
T-bet-positive and IRTA1-positive monocytoid B cells differ from marginal zone B cells and epithelial-associated B cells in their antigen profile and topographical distribution. 45
Gene expression profiling of hairy cell leukemia reveals a phenotype related to memory B cells with altered expression of chemokine and adhesion receptors 44
A BRAF-mutated case of hairy cell leukaemia lacking Annexin-A1 expression 44
New treatment options in hairy cell leukemia with focus on BRAF inhibitors 43
Immunohistochemical surrogates for genetic alterations of CCDN1, PML, ALK, and NPM1 genes in lymphomas and acute myeloid leukemia. 42
A case of concomitant chronic lymphocytic leukaemia and hairy cell leukaemia evaluated for IGHV-D-J rearrangements and BRAF-V600E mutation: lack of evidence for a common origin 42
Constant Activation of the RAF-MEK-ERK Pathway As a Diagnostic and Therapeutic Target in Hairy Cell Leukemia. 42
Identification and Characterization of Novel Rare Nucleophosmin (NPM1) Gene Mutations in Acute Myeloid Leukemia (AML) By a Combinatorial Approach of Immunohistochemistry and Molecular Analyses 42
Biological and therapeutic relevance of the BRAF-MEK-ERK pathway in hairy cell leukemia 42
A novel patient-derived tumorgraft model with TRAF1-ALK anaplastic large-cell lymphoma translocation 42
Simple genetic diagnosis of hairy cell leukemia by sensitive detection of the BRAF-V600E mutation. 41
THE BRAF INHIBITOR VEMURAFENIB IS SAFE AND HIGHLY EFFECTIVE IN REFRACTORY AND RELAPSED HAIRY CELL LEUKEMIA: RESULTS OF THE HCL-PG01 PHASE-2 ITALIAN CLINICAL TRIAL 41
Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype 40
The genetics of nodal marginal zone lymphoma 40
Origin and pathogenesis of nodular lymphocyte-predominant Hodgkin lymphoma as revealed by global gene expression analysis. 39
Safety and efficacy of the BRAF inhibitor dabrafenib in relapsed or refractory hairy cell leukemia: a pilot phase-2 clinical trial 39
Lymphoma 36
Dissecting Clonal Hematopoiesis in Tissues of Classical Hodgkin Lymphoma Patients 35
PAX5 expression in acute leukemias: higher B-lineage specificity than CD79a and selective association with t(8;21)-acute myelogenous leukemia 34
Whole-exome sequencing identifies somatic mutations of BCOR in acute myeloid leukemia with normal karyotype 34
Haploidentical peripheral-blood stem-cell transplantation for ALK-positive anaplastic large-cell lymphoma. 34
New classification of acute myeloid leukemia and precursor-related neoplasms: changes and unsolved issues. 33
The corepressors BCOR and BCORL1: two novel players in acute myeloid leukemia. 33
Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia 33
Frequent traces of EBV infection in Hodgkin and non-Hodgkin lymphomas classified as EBV-negative by routine methods: expanding the landscape of EBV-related lymphomas [Tiacci and Lazzi are co-senior authors] 33
IRTA1+ monocytoid B cells in reactive lymphadenitis show a unique topographic distribution and immunophenotype and a peculiar usage and mutational pattern of IgVH genes. 32
Identification of a new subclass of ALK negative ALCL expressing aberrant levels of ERBB4 transcripts 31
Transformation of IGHV4-34+ hairy cell leukaemia-variant with U2AF1 mutation into a clonally-related high grade B-cell lymphoma responding to immunochemotherapy 31
Identification of novel STAT5B mutations and characterization of TCRβ signatures in CD4+ T-cell large granular lymphocyte leukemia 31
Mutations in the genes coding for the NF-κB regulating factors IκBα and A20 are uncommon in nodular lymphocyte-predominant Hodgkin's lymphoma. 30
The Kruppel-like factor 2 transcription factor gene is recurrently mutated in splenic marginal zone lymphoma 30
A curious novel combination of nucleophosmin (Npm1) gene mutations leading to aberrant cytoplasmic dislocation of npm1 in acute myeloid leukemia (aml) 30
Expression of the IRTA1 receptor identifies intraepithelial and subepithelial marginal zone B cells of the mucosa-associated lymphoid tissue (MALT). 29
High expression of several tyrosine kinases and activation of the PI3K/AKT pathway in mediastinal large B cell lymphoma reveals further similarities to Hodgkin lymphoma. 29
Novel NPM1 exon 5 mutations and gene fusions leading to aberrant cytoplasmic nucleophosmin in AML 29
How I treat refractory/relapsed hairy cell leukemia with BRAF inhibitors 28
Gene dosage effects in chronic lymphocytic leukemia. 27
Identification of candidate tumour suppressor gene loci for Hodgkin and Reed-Sternberg cells by characterisation of homozygous deletions in classical Hodgkin lymphoma cell lines. 27
Hairy cell leukaemia mimicking multiple myeloma 27
Defining TCRγδ lymphoproliferative disorders by combined immunophenotypic and molecular evaluation 23
[Global gene expression analysis and novel signalling pathways in Hodgkin lymphoma] 23
SAVI: a statistical algorithm for variant frequency identification. 22
Subclonal evolution of a classical Hodgkin lymphoma from a germinal center B-cell-derived mantle cell lymphoma. [Tiacci, Mecucci and Kueppers are co-senior authors] 21
Human CD30+ B cells represent a unique subset related to Hodgkin lymphoma cells 21
Acute myeloid leukemia development soon after anti-CD19 chimeric antigen receptor T-cell infusion in a patient with refractory diffuse large B-cell lymphoma and pre-existing clonal hematopoiesis 18
Anaplastic large-cell lymphoma 18
Genetics of classical Hodgkin Lymphoma [Educational Program of the 23th Congress of the European Hematology Association] 15
Vemurafenib plus Rituximab in Refractory or Relapsed Hairy-Cell Leukemia 14
Hairy cell leukemia and COVID-19 adaptation of treatment guidelines 13
SARS-CoV-2 infection and vaccination in patients with hairy-cell leukaemia 12
Vemurafenib and rituximab in patients with hairy cell leukemia previously treated with moxetumomab pasudotox 12
The current role of interferon in hairy cell leukaemia: clinical and molecular aspects 11
Overlapping features of therapy-related and de novoNPM1-mutated AML 10
Long-term follow-up of cladribine treatment in hairy cell leukemia: 30-year experience in a multicentric Italian study 8
Venetoclax in Relapsed or Refractory Hairy-Cell Leukemia 8
The gene mutation landscape of acute myeloid leukemia cell lines and its exemplar use to study the BCOR tumor suppressor 7
One disease, two faces: clonally-related AML and MPDCP with skin involvement 6
Correction to: One disease, two faces: clonally-related AML and MPDCP with skin involvement 6
Genomic landscape of virus-associated cancers 4
Totale 4.164
Categoria #
all - tutte 14.694
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.694


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201955 0 0 0 0 0 0 0 1 17 4 31 2
2019/2020286 10 6 28 4 31 7 38 7 42 87 10 16
2020/2021716 7 40 14 42 191 36 33 43 102 22 48 138
2021/2022925 16 155 4 21 24 8 12 233 59 71 197 125
2022/20231.504 97 268 17 115 101 146 13 53 579 43 58 14
2023/2024318 42 42 43 17 22 9 140 3 0 0 0 0
Totale 4.178